A continuum of capabilities
A support at every stage of the product lifecycle
With 25 years of experience in process development, scale-up and ongoing cGMP manufacturing of small molecule APIs, we support emerging, specialty and large pharmaceutical customers for their drug substance or drug delivery needs.Discover
Highly efficient manufacturing capabilities
As a fully integrated CDMO, Seqens is uniquely positioned to address the continuum of the API value chain : API, HPAPI, cGMP & non-GMP intermediates, RSM, controlled substances, excipient for drug deliveryDiscover
A trusted supplier
of proprietary APIs
More than 50 APIs have been successfully launched in the United States, Europe and Japan with consistently superior quality, reliability and customer service, supported by regulatory documentation to meet the most stringent standards from local agenciesDiscover
A continuum of technologies
8 industrial plants and 3 R&D centers in Europe, North America and Asia.
More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.
The benefits of Mixed cGMP and Pre-GMP environments for API Manufacturing
What is driving the growing demand for lyophilization?
Seqens North America Receives CMO Leadership Award for Reliability – Part 2
Sales Account Manager – Permanent Contract
Seqens CDMO global presenceUse interactive map
6 cGMP/FDA inspected sites in EU & US
Pre-GMP sites for RSMs & Intermediates
DMFs for commercial APIs
Scientists, experts and engineers
R&D centers in UE and US